Drug information provided by: Merative, Micromedex
Aspirin 81 Mg-Omeprazole 40 Mg Tablet,Immediate And Delayed Release Low Dose (81 Or Less) - Uses, Side Effects, and More Uses This combination product contains two medications: Dosage form: oral delayed release tablet (325 mg-40 mg; 81 mg-40 mg) Drug class: Platelet aggregation inhibitors Medically reviewed by Drugs
Each tablet contains 81 or 325 milligrams (mg) of aspirin and 40 mg of omeprazole
Tablet
Applies to the following strengths: 81 mg-40 mg; 325 mg-40 mg Usual Adult Dose for: Thromboembolic Stroke Prophylaxis Ischemic Stroke - Prophylaxis Cardiovascular Risk Reduction Gastric Ulcer Prophylaxis Yosprala (aspirin / omeprazole) is available in different strengths, so make sure you know which strength you're taking
Copyright (c) 2024 First Databank, Inc
Take omeprazole capsules or delayed-release capsules before a meal, preferably in the morning
Omeprazole is a proton pump inhibitor that decreases the amount of acid produced in the stomach
Gastric and duodenal ulcer formation was assessed by gastroduodenal endoscopy at screening and after 1, 3, and 6 months of treatment
Patients were included with a cerebro- or cardiovascular diagnosis if they Another trial dealt with the issue of the long-term GI safety of PA32540 (ECA 325 mg and immediate-release omeprazole 40 mg), and the final trial studied the effects of misoprostol on patients who developed gastric ulcers while undergoing low-dose ECA therapy
3-fold higher AUC and 2-fold higher C max of Pronunciation: oh-MEP-ra-zol Generic name: omeprazole Brand names: FIRST Omeprazole, Omeprazole + SyrSpend SF Alka, PriLOSEC, PriLOSEC OTC, Zegerid (Original Formulation) Dosage forms: oral delayed release capsule (10 mg; 20 mg; 40 mg), oral delayed release tablet (20 mg), show all 4 dosage forms Drug class: Proton pump inhibitors Protonix 40mg is used as a preventive measure in the fight against cancer and stomach ulcer
PA32540 is a coordinated-delivery, combination tablet consisting of enteric-coated aspirin (EC-ASA) 325 mg and immediate-release (IR) omeprazole 40 mg
โอเมพราโซล
The risk of interactions with omeprazole is greater than with other PPIs such as lansoprazole and pantoprazole
Drug information provided by: Merative, Micromedex
Omeprazole DR 40-mg can cause the same types of side effects as the other strengths
YOSPRALA is newly designed tablet which effective in cardiovascular as well as gastrointestinal protection due to its immediate release of Omeprazole (40 mg) and delayed release of Aspirin (81 mg) or (325 mg) dose strength
It relieves symptoms such as • 81 mg delayed-release aspirin and 40 mg immediate-release omeprazole, printed with 81/40, or • 325 mg delayed-release aspirin and 40 mg immediate-release omeprazole, printed with 325/40
CONTRAINDICATIONS
Efficacy of aspirin (325 mg) + omeprazole (40 mg) in treating coronary artery disease
Omeprazole termasuk obat keras, yang hanya bisa didapatkan dan digunakan melalui resep dokter
Omeprazole (Prilosec) is available both over the counter (OTC) and by prescription
Dosing recommendations may vary among individual products and between countries (refer to specific product guidelines)
This medicine can affect the PA32540 is a coordinated-delivery tablet consisting of an inner core of enteric-coated aspirin (EC-ASA) 325 mg surrounded by an outer layer of immediate-release (IR) omeprazole 40 mg
It works by decreasing the amount of acid your stomach makes
Call your doctor at once if you have: severe stomach pain, diarrhea that is watery or bloody; seizure (convulsions); kidney problems-- fever, rash, nausea, loss of appetite, joint pain, urinating less than usual, blood in your urine, weight gain; low magnesium--dizziness, fast or irregular heart rate Each delayed-release tabletu00a0containsu00a0either 81 mg aspirin and 40 mg omeprazole printed with 81/40, or 325 mg aspirin and 40 mg omeprazole printed with 325/40
Este medicamento se usa para las siguientes afecciones: prevenir accidentes cerebrovasculares
This may lead to Yosprala is indicated for patients who require aspirin for secondary prevention of cardiovascular and cerebrovascular events, as well as those at risk of developing aspirin-associated gastric ulcers
To treat duodenal ulcer: Adults—20 milligrams (mg) once a day for 4 to 8 weeks
Treatment of NSAID-associated gastric and duodenal ulcers
Nausea (3%) Diarrhea (3%) Gastric polyps (2%) Noncardiac chest pain (2%) 1%
However, its use may be associated with gastrointestinal (GI) toxicities, including, but not limited to, GI bleeding
Each tablet contains 81 or 325 milligrams (mg) of aspirin and 40 mg of omeprazole
The tablet consists of an enteric-coated delayed-release aspirin core surrounded by an immediate-release omeprazole layer
Each delayed-release tablet contains either 81 mg aspirin and 40 mg omeprazole printed with 81/40, or 325 mg aspirin and 40 mg omeprazole printed with 325/40
Aspirin is as platelet aggregation inhibitor
ASPIRIN AND OMEPRAZOLE DELAYED-RELEASE TABLETSA is a combination of aspirin, an anti-platelet agent, and omeprazole, a proton pump inhibitor
hr/mL following single dose administration of ASPIRIN AND OMEPRAZOLE
PA32540 is a novel fixed-dose, coordinated-delivery tablet containing enteric-coated (EC)-ASA 325 mg and immediate-release omeprazole 40 mg
997
It is used to treat gastric and duodenal ulcers, erosive esophagitis, and gastroesophageal reflux disease (GERD)
Secondary prevention of cardiovascular and cerebrovascular events: Oral: One tablet (aspirin 81 mg/omeprazole 40 mg or aspirin 325 mg/omeprazole 40 mg) once daily
PA32540 (a coordinated-delivery tablet of enteric-coated aspirin 325 mg and immediate-release omeprazole 40 mg) versus enteric-coated aspirin 325 mg alone in subjects at risk for aspirin-associated gastric ulcers: results of two 6-month, phase 3 studies
Gastric and duodenal ulcer formation was assessed by gastroduodenal endoscopy at screening and after 1, 3, and 6 months of treatment
Dosis pemeliharaan: 10-20 mg diminum 1 kali per hari
PA32540 [enteric-coated aspirin (EC-ASA) 325 mg + immediate-release omeprazole 40 mg] was compared with EC-ASA 325 mg alone once daily for 6 months in 2 duplicate, randomized double-blind trials in gastrointestinal-risk patients taking aspirin for ≥3 months for secondary prevention
The usual dose is once daily, 1 hour before a meal
Each delayed-release tablet contains either 81 mg aspirin and 40 mg omeprazole printed with 81/40, or 325 mg aspirin and 40 mg omeprazole printed with 325/40
Omeprazole Interactions
The inactive ingredients in